BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PALB2 Interest Group - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.palb2.org
X-WR-CALDESC:Events for PALB2 Interest Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260414T080000
DTEND;TZID=Europe/London:20260507T170000
DTSTAMP:20260602T195138
CREATED:20260324T113253Z
LAST-MODIFIED:20260324T113255Z
UID:1600-1776153600-1778173200@www.palb2.org
SUMMARY:Goodbye Breasts! 
DESCRIPTION:An award-winning feature documentary by Joanna Callaghan. \n\n\n\nBook Tickets \n\n\n\nWatch the trailer \n\n\n\nVisit the website   \n\n\n\nFollow us Facebook & Instagram \n\n\n\n\n\n\n\n\n\nResearch profile
URL:https://www.palb2.org/event/goodbye-breasts/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251203T170000
DTEND;TZID=Europe/London:20251203T180000
DTSTAMP:20260602T195138
CREATED:20251119T083658Z
LAST-MODIFIED:20251119T084957Z
UID:1571-1764781200-1764784800@www.palb2.org
SUMMARY:5th Annual PALB2 information Session for patients and families
DESCRIPTION:Our 5th UK Annual PALB2 formation Session is designed for people of all genders who carry a PALB2 gene mutation and would like to learn more about the gene and its implications. \n\n\n\nThe session will cover the latest research (including updates related to pancreatic cancer)\, current UK guidelines for PALB2 risk management\, emerging treatment options\, emotional wellbeing\, and sources of support for carriers and their families. \n\n\n\nAlthough our expert panel is UK-based and the primary focus is on UK guidance\, everyone is welcome to attend. Age 16+. \n\n\n\nSESSION PROGRAMME: Palb2 information session – 3 December 2025Download\n\n\n\nSESSION DETAILS  \n\n\n\nThe meeting will be on Teams – please use the link below: \n\n\n\nTime: 3 December 2025 17:00-18:00 GMT (London) \n\n\n\nMicrosoft Teams Need help? \n\n\n\nJoin the meeting now \n\n\n\nMeeting ID: 326 178 981 803 13 \n\n\n\nPasscode: AW6Dh6YF \n\n\n\n\n\n\n\n\n\nAgenda – Expert Panel Discussion & Q&A(facilitated by Yulia Baynham) \n\n\n\nPALB2 gene: latest research and risk-management guidanceProfessor Marc Tischkowitz and Dr Anju Kulkarni \n\n\n\nPancreatic cancer risks and surveillanceDr Michael Chapman \n\n\n\nQ&A session\, including questions submitted in advance and live questions from participantsYulia Baynham\, PALB2 carrier \n\n\n\nPanellists: \n\n\n\n\n\n\n\nProfessor Marc Tischkowitz is a Consultant Clinical Geneticist and Lead for the Cancer Genetics service in East Anglia. He trained in Medical Oncology and Medical Genetics before moving to Canada\, where he was in the Faculty at McGill University for six years before coming to Cambridge in 2011. Much of his research has been on the PALB2 and hereditary breast cancer predisposition but his interests cover all areas of hereditary cancer and translating the recent advances in genomic technology into clinical practice. He is a founding member of the Global PALB2 Interest Group.Dr Michael Chapman is Consultant Gastroenterologist\, University College Hospital\, London\, where he also runs the EUROPAC clinic. Dr Chapman qualified in 1997 from UCL Medical School and completed specialist training in London. His practice includes general gastroenterology with a specialist interest in pancreatobiliary medicine and hepatology. Conditions of particular interest include primary sclerosing cholangitis\, IgG4 related cholangitis and pancreatitis\, gallstones\, chronic pancreatitis\, hereditary pancreatitis\, duodenal polyps\, pancreatic cancer and cholangiocarcinoma. Dr Anju Kulkarni is a Consultant Clinical Geneticist and Lead for the Cancer Genetics service at Guy’s and St Thomas’ NHS Foundation Trust. She graduated from Imperial College School of Medicine and trained at specialist level in both Medical Oncology and Clinical Genetics. Anju leads multidisciplinary specialist clinics for BRCA1/2 gene mutation carriers and rarer hereditary cancer conditions (including PALB2). She holds several regional and national roles\, including council member of the UK Cancer Genetics Group and medical advisor to the UK Genetic Counselling Registration Board. Dr Vishakha Tripathi is a Consultant Genetic Counsellor at Guy’s and St Thomas’ NHS Foundation Trust. She has varied background ranging from special needs teaching\, medicine and genetic counselling. She currently leads the hereditary breast and ovarian cancer service (HBOC) at Guy’s and through this work contributes to research in all areas of cancer genetics. Nationally\, Vishakha has been Chair of the Genetic Counsellor Registration Board (GCRB) and is a member of the Clinical Genetics\, Clinical Reference Group for NHS England. She also leads a successful cancer genetics course which has trained numerous family history nurses and clinicians in cancer care. (Standing member of the panel\, advance Q&A responses)\n\n\n\nPrevious sessions/ reference documents \n\n\n\n\n1st UK PALB2 webinar (Sept 2020) – link to recording Background to PALB2\, latest research and genetic developments; managing own cancer risk and risks within your families; \n\nSharing the information about the gene with others; resources\n\n\n\n\n\n2nd UK PALB2 webinar (September 2021) – link to recording\n\n\n\nACMG International guidelines in PALB2 management\n\n\n\nTargeted therapies and new treatment options\n\n\n\nPALB2 Patient information booklet published in November 2021\n\n\n\n\n\n3rd UK PALB2 webinar (Oct 2022) – link to recording\n\nPALB2 – latest research and genetic developments; Patient stories; Q&As received in advance and from the audience\n\n\n\n\n\n4th UK PALB2 webinar (Oct 2024) – link to recording\n\nPALB2 – latest research and genetic developments; Patient journey; Q&As received in advance and from the audience\n\n\n\n\n\n\n\n\nT
URL:https://www.palb2.org/event/5th-uk-annual-palb2-formation-session/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210930T170000
DTEND;TZID=Europe/London:20210930T180000
DTSTAMP:20260602T195138
CREATED:20210914T074531Z
LAST-MODIFIED:20210914T074531Z
UID:1180-1633021200-1633024800@www.palb2.org
SUMMARY:PALB2 information evening  - Sep 30\, 2021 17:00-18:00 London
DESCRIPTION:Our 2nd UK annual event is aimed at women and men who have a PALB2 gene mutation and who would like to get further information about the gene. We shall cover the latest research\, international guidelines for PALB2 risk management\, new treatment options\, and where gene carriers and their families can find more information. Due to the panel being UK based\, our target audience for the talk will be the UK carriers\, although others are welcome.\nOur first session from 2020 can be found on YouTube here – link. Please do listen to it first as useful background information.\nEvent timing (GMT): 17:00 start with Expert Panel and Q&As with participants\nTo attend\, please see Zoom details on the next page or use this link http://www.palb2.org/events. In order to meet the demand and due to capacity\, we would like to ask if you can join on your own or with one family member/ a friend from the same location. Age 16+.\nPanellists: \nProfessor Marc Tischkowitz is a Consultant Clinical Geneticist and Lead for the Cancer Genetics service in East Anglia. He trained in Medical Oncology and Medical Genetics before moving to Canada\, where he was in the Faculty at McGill University for six years before coming to Cambridge in 2011. Much of his research has been on the PALB2 and hereditary breast cancer predisposition but his interests cover all areas of hereditary cancer and translating the recent advances in genomic technology into clinical practice.\nHe is a founding member of the Global PALB2 Interest Group \nJennifer Wiggins is a registered genetic counsellor (UK) who has worked in clinical genetics since 1996. She is currently a senior genetic counsellor at The Royal Marsden NHS Foundation Trust\, London\, UK\nShe developed ‘The Beginner’s Guide to BRCA1 and BRCA2’ and ‘The Beginner’s Guide to Lynch syndrome’ and published the genetic counselling book ‘Getting the Message Across: Communication in Diverse Populations in Clinical Genetics’ which examines barriers to communication with genetic patients and discusses techniques for ensuring patients’ understanding of their genetic assessment is optimised. She was on the committee of the Association of Genetic Nurses and Counsellors (AGNC) and is currently on the Board of the GCRB. \nDr Anju Kulkarni is a Consultant Clinical Geneticist and Lead for the Cancer Genetics service at Guy’s and St Thomas’ NHS Foundation Trust. She graduated from Imperial College School of Medicine and trained at specialist level in both Medical Oncology and Clinical Genetics. Anju leads multidisciplinary specialist clinics for BRCA1/2 gene mutation carriers and rarer hereditary cancer conditions (including PALB2). She holds several regional and national roles\, including council member of the UK Cancer Genetics Group and medical advisor to the UK Genetic Counselling Registration Board. \nDr Vishakha Tripathi is a Consultant Genetic Counsellor at Guy’s and St Thomas’ NHS Foundation Trust. She has varied background ranging from special needs teaching\, medicine and genetic counselling. She currently leads the hereditary breast and ovarian cancer service (HBOC) at Guy’s and through this work contributes to research in all areas of cancer genetics. Nationally\, Vishakha has been Chair of the Genetic Counsellor Registration Board (GCRB) and is a member of the Clinical Genetics\, Clinical Reference Group for NHS England. She also leads a successful cancer genetics course which has trained numerous family history nurses and clinicians in cancer care. \nProfessor Andrew Tutt is Director of the Breast Cancer Now Toby Robins Research Centre at the ICR and the Breast Cancer Now Research Unit at Guy’s Hospital King’s College London. He is a Clinician Scientist with two research laboratories and a clinical trials programme\, and he cares for women with breast cancer as a Consultant Oncologist\, and as a member of the multidisciplinary Breast Units at Guy’s and St Thomas’ and Royal Marsden NHS Foundation Trusts.\nHe has a particular research interest in BRCA1/2 and PALB2 associated breast cancers and leads a clinical trial programme focusing on TNBC and cancers associated with functional deficiencies in BRCA1 and BRCA2. His translational laboratories at both the ICR and KCL\, study BRCA1 and BRCA2 associated and Triple Negative forms of breast cancer (TNBC). \nYulia Baynham\, Palb2 gene carrier Diagnosed with Breast Cancer in January 2019\, Yulia underwent comprehensive treatment. During that time\, she was tested positive for PALB2 gene alteration with a pathogenic variant (meaning the gene was hereditary).\nYulia is the organiser of the event and will facilitate the session. She is also a Trustee of the Olive Tree Cancer Support Group\, charity based in Crawley and Horsham areas of West Sussex\, that supports those with cancer and their families. \nTopic: PALB2 information evening\nTime: Sep 30\, 2021 17:00-18:00 London \nJoin Zoom Meeting\nhttps://us06web.zoom.us/j/89137899394 \nMeeting ID: 891 3789 9394\nOne tap mobile\n+442034815240\,\,89137899394# The United Kingdom\n+442039017895\,\,89137899394# The United Kingdom \nDial by your location\n+44 203 481 5240 The United Kingdom\n+44 203 901 7895 The United Kingdom\n+44 208 080 6591 The United Kingdom\n+44 208 080 6592 The United Kingdom\n+44 330 088 5830 The United Kingdom\n+44 131 460 1196 The United Kingdom\n+44 203 481 5237 The United Kingdom\nMeeting ID: 891 3789 9394\nFind your local number: https://us06web.zoom.us/u/kbiUcdLH6X\nPalb2 information session – 30 September 2021 FINAL
URL:https://www.palb2.org/event/palb2-information-evening-sep-30-2021-1700-1800-london/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200924T170000
DTEND;TZID=Europe/London:20200924T180000
DTSTAMP:20260602T195138
CREATED:20200807T080738Z
LAST-MODIFIED:20200807T080738Z
UID:1151-1600966800-1600970400@www.palb2.org
SUMMARY:PALB2 Information Session by Zoom
DESCRIPTION:This event is aimed at women and men who have a PALB2 gene mutation and who would like to get further information about the gene. We shall cover the latest research and genetic developments\, how to manage your cancer risk and risks within your families\, new treatment options on the horizon\, and how best to share the information about the gene with others (families and friends). \nMeeting ID: 951 0654 2247\nEvent timing (GMT): 17:00 start with Expert Panel and Q&As with participants \n\n\n\n\n\n\n\n\nTopic: PALB2 Information session \nTime: Sep 24\, 2020 05:00 PM Palb2 information session – 24 September 2020 (final).docx Zoom Meeting \nhttps://zoom.us/j/95106542247 \nMeeting ID: 951 0654 2247 \n\n\n\n\n\n\n\n\nOne tap mobile\n+442080806591\,\,95106542247# United Kingdom +442080806592\,\,95106542247# United Kingdom \nDial by your location\n+44 208 080 6591 United Kingdom +44 208 080 6592 United Kingdom +44 330 088 5830 United Kingdom +44 131 460 1196 United Kingdom +44 203 481 5237 United Kingdom +44 203 481 5240 United Kingdom \n+44 203 901 7895 United Kingdom\nFind your local number: https://zoom.us/u/acrofuM2mB
URL:https://www.palb2.org/event/palb2-information-session-by-zoom/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191017T011500
DTEND;TZID=Europe/London:20191017T030000
DTSTAMP:20260602T195138
CREATED:20191007T144625Z
LAST-MODIFIED:20191007T144625Z
UID:1107-1571274900-1571281200@www.palb2.org
SUMMARY:PALB2 Interest Group Meeting ASHG Houston 2019
DESCRIPTION:Date: Wednesday\, October 16\, 2019 \nTime: 7:15-9:00 PM \nVenue: George R. Brown Convention Center; Room 381BC\, Level 3
URL:https://www.palb2.org/event/palb2-interest-group-meeting-ashg-houston-2019/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190213T080000
DTEND;TZID=Europe/London:20190213T170000
DTSTAMP:20260602T195138
CREATED:20190213T100917Z
LAST-MODIFIED:20190213T100930Z
UID:1089-1550044800-1550077200@www.palb2.org
SUMMARY:PALB2- IG meeting at ASHG\, Houston\, October 2019
DESCRIPTION:Our next PALB2 meeting is planned for ASHG in October 2019. More details to follow
URL:https://www.palb2.org/event/palb2-ig-meeting-at-ashg-houston-october-2019/
END:VEVENT
END:VCALENDAR